BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6476484)

  • 1. Effects of chronic aspirin ingestion in aspirin-intolerant asthmatic patients.
    Naeije N; Bracamonte M; Michel O; Sergysels R; Duchateau J
    Ann Allergy; 1984 Sep; 53(3):262-4. PubMed ID: 6476484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic aspirin ingestion in aspirin-intolerant asthmatic patients.
    Chiu JT
    Ann Allergy; 1985 Mar; 54(3):259. PubMed ID: 3977142
    [No Abstract]   [Full Text] [Related]  

  • 3. Decreased sensitivity to tartrazine after aspirin desensitization in an asthmatic patient intolerant to both aspirin and tartrazine.
    Michel O; Naeije N; Bracamonte M; Duchateau J; Sergysels R
    Ann Allergy; 1984 May; 52(5):368-70. PubMed ID: 6721262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspects of bronchial reactivity to prostaglandins and aspirin in asthmatic patients.
    Pasargiklian M; Bianco S; Allegra L; Moavero NE; Petrigni G; Robuschi M; Grugni A
    Respiration; 1977; 34(2):78-91. PubMed ID: 407642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reactions to metabisulfites in aspirin-induced asthma].
    Sabbah A; Drouet M; Bonneau JC; Le Sellin J
    Allerg Immunol (Paris); 1987 Jan; 19(1):25-8. PubMed ID: 3454169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin "desensitization" in patients with aspirin-induced urticaria and angioedema.
    Grzelewska-Rzymowska I; Roznlecki J; Szmidt M
    Allergol Immunopathol (Madr); 1988; 16(5):305-8. PubMed ID: 3228050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
    Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
    J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma.
    Gaber F; Daham K; Higashi A; Higashi N; Gülich A; Delin I; James A; Skedinger M; Gyllfors P; Nord M; Dahlén SE; Kumlin M; Dahlén B
    Thorax; 2008 Dec; 63(12):1076-82. PubMed ID: 18757457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases.
    Fraj J; Valero A; Vives R; Pérez I; Borja J; Izquierdo I; Picado C
    Allergy; 2008 Jan; 63(1):112-5. PubMed ID: 18053020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and other cross-reacting small chemicals in known aspirin intolerant patients.
    Fisherman EW; Cohen GN
    Ann Allergy; 1973 Oct; 31(10):476-84. PubMed ID: 4768545
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolysis, blood coagulation, and platelet function during aspirin-induced bronchoconstriction in aspirin-intolerant asthmatics.
    Kowalski ML; Grzelewska-Rzymowska I; Szmidt M; Rozniecki J; Bednarowicz A
    Ann Allergy; 1987 May; 58(5):367-71. PubMed ID: 3578930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity in aspirin-tolerant and aspirin-intolerant asthmatics.
    Jang AS; Park JS; Park SW; Kim DJ; Uh ST; Seo KH; Kim YH; Park HS; Park CS
    Respirology; 2008 Nov; 13(7):1034-8. PubMed ID: 18699807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease.
    Hope AP; Woessner KA; Simon RA; Stevenson DD
    J Allergy Clin Immunol; 2009 Feb; 123(2):406-10. PubMed ID: 19056109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity.
    Mastalerz L; Sanak M; Gawlewicz-Mroczka A; Gielicz A; Cmiel A; Szczeklik A
    Thorax; 2008 Jan; 63(1):27-34. PubMed ID: 17584993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease.
    Berges-Gimeno MP; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2003 Mar; 90(3):338-41. PubMed ID: 12669898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges.
    Williams AN; Simon RA; Woessner KM; Stevenson DD
    J Allergy Clin Immunol; 2007 Aug; 120(2):273-7. PubMed ID: 17481713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients.
    Sanak M; Kiełbasa B; Bochenek G; Szczeklik A
    Clin Exp Allergy; 2004 Dec; 34(12):1899-904. PubMed ID: 15663565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of aspirin desensitization in patients with aspirin-induced asthma].
    Sulakvelidze IV; Kruglyĭ BI
    Probl Tuberk; 1988; (6):48-50. PubMed ID: 3211880
    [No Abstract]   [Full Text] [Related]  

  • 19. The safety of celecoxib in patients with aspirin-sensitive asthma.
    Woessner KM; Simon RA; Stevenson DD
    Arthritis Rheum; 2002 Aug; 46(8):2201-6. PubMed ID: 12209526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of prostacyclin on asthma precipitated by aspirin.
    Nizankowska E; Czerniawska-Mysik G; Szczeklik A
    Allerg Immunol (Paris); 1987 Jan; 19(1):22-4. PubMed ID: 3331264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.